CA3155829A1 - PC945 TRIAZOLE ANTIFUNGAL COMPOUND POLYMORPHS - Google Patents
PC945 TRIAZOLE ANTIFUNGAL COMPOUND POLYMORPHSInfo
- Publication number
- CA3155829A1 CA3155829A1 CA3155829A CA3155829A CA3155829A1 CA 3155829 A1 CA3155829 A1 CA 3155829A1 CA 3155829 A CA3155829 A CA 3155829A CA 3155829 A CA3155829 A CA 3155829A CA 3155829 A1 CA3155829 A1 CA 3155829A1
- Authority
- CA
- Canada
- Prior art keywords
- polymorphs
- antifungal compound
- triazole antifungal
- compound
- triazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1917867.2A GB201917867D0 (en) | 2019-12-06 | 2019-12-06 | Polymorphs |
| GB1917867.2 | 2019-12-06 | ||
| PCT/GB2020/053107 WO2021111142A1 (en) | 2019-12-06 | 2020-12-04 | Polymorphs of triazole antifungal compound pc945 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3155829A1 true CA3155829A1 (en) | 2021-06-10 |
Family
ID=69171938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3155829A Pending CA3155829A1 (en) | 2019-12-06 | 2020-12-04 | PC945 TRIAZOLE ANTIFUNGAL COMPOUND POLYMORPHS |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US12491182B2 (https=) |
| EP (2) | EP4509179A3 (https=) |
| JP (1) | JP2023505227A (https=) |
| KR (1) | KR20220110726A (https=) |
| CN (1) | CN114746415B (https=) |
| AU (1) | AU2020397613A1 (https=) |
| BR (1) | BR112022006259A2 (https=) |
| CA (1) | CA3155829A1 (https=) |
| CL (1) | CL2022001464A1 (https=) |
| CO (1) | CO2022007808A2 (https=) |
| DK (1) | DK4069690T3 (https=) |
| ES (1) | ES3000984T3 (https=) |
| FI (1) | FI4069690T3 (https=) |
| GB (1) | GB201917867D0 (https=) |
| HR (1) | HRP20250042T1 (https=) |
| HU (1) | HUE069799T2 (https=) |
| IL (1) | IL293401A (https=) |
| LT (1) | LT4069690T (https=) |
| MX (1) | MX2022006654A (https=) |
| PL (1) | PL4069690T3 (https=) |
| PT (1) | PT4069690T (https=) |
| RS (1) | RS66401B1 (https=) |
| SA (1) | SA522432879B1 (https=) |
| SI (1) | SI4069690T1 (https=) |
| SM (1) | SMT202400514T1 (https=) |
| WO (1) | WO2021111142A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3227277B1 (en) | 2014-12-05 | 2020-02-05 | Pulmocide Limited | Antimycotic compound |
| CN117510488B (zh) * | 2022-07-28 | 2025-12-05 | 博瑞制药(苏州)有限公司 | 一种硫酸艾沙康唑的制备方法 |
| CN117330660A (zh) * | 2023-09-14 | 2024-01-02 | 广州医科大学附属第一医院（广州呼吸中心） | Uplc-ms/ms联用检测艾沙康唑的方法及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1292472C (en) | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| DE3852477T2 (de) | 1987-11-20 | 1995-05-04 | Schering Corp | Tri- und tetrasubstituierte Oxetane und Tetrahydrofurane und deren Zwischenprodukte. |
| US5039676A (en) | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| US5714490A (en) | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
| PL181193B1 (pl) | 1993-12-21 | 2001-06-29 | Schering Corp | Nowe pochodne tetrahydrofuranowe o działaniu przeciwgrzybicznym, kompozycja farmaceutyczna do leczenia infekcji grzybiczych oraz sposób wytwarzania tych związków |
| US5486625A (en) | 1994-07-08 | 1996-01-23 | Schering Corporation | Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
| HUP9701690A3 (en) | 1995-06-02 | 1998-04-28 | Schering Corp Kenilwort | Tetrahydrofuran derivatives as antifungals and pharmaceutical compositions containing the same |
| EP0957101A1 (en) | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
| EP1372394A1 (en) | 2001-04-03 | 2004-01-02 | Schering Corporation | Antifungal composition with enhanced bioavailability |
| EP2141159A1 (en) * | 2008-07-03 | 2010-01-06 | Sandoz AG | A Crystalline form of posaconazole |
| US9346791B2 (en) | 2011-09-07 | 2016-05-24 | The Johns Hopkins University | Itraconazole analogs and use thereof |
| EP3227277B1 (en) | 2014-12-05 | 2020-02-05 | Pulmocide Limited | Antimycotic compound |
-
2019
- 2019-12-06 GB GBGB1917867.2A patent/GB201917867D0/en not_active Ceased
-
2020
- 2020-12-04 AU AU2020397613A patent/AU2020397613A1/en active Pending
- 2020-12-04 FI FIEP20824979.7T patent/FI4069690T3/fi active
- 2020-12-04 CA CA3155829A patent/CA3155829A1/en active Pending
- 2020-12-04 PT PT208249797T patent/PT4069690T/pt unknown
- 2020-12-04 BR BR112022006259A patent/BR112022006259A2/pt unknown
- 2020-12-04 ES ES20824979T patent/ES3000984T3/es active Active
- 2020-12-04 RS RS20250045A patent/RS66401B1/sr unknown
- 2020-12-04 EP EP24212504.5A patent/EP4509179A3/en active Pending
- 2020-12-04 CN CN202080082529.6A patent/CN114746415B/zh active Active
- 2020-12-04 SM SM20240514T patent/SMT202400514T1/it unknown
- 2020-12-04 IL IL293401A patent/IL293401A/en unknown
- 2020-12-04 SI SI202030565T patent/SI4069690T1/sl unknown
- 2020-12-04 JP JP2022533459A patent/JP2023505227A/ja active Pending
- 2020-12-04 HR HRP20250042TT patent/HRP20250042T1/hr unknown
- 2020-12-04 MX MX2022006654A patent/MX2022006654A/es unknown
- 2020-12-04 PL PL20824979.7T patent/PL4069690T3/pl unknown
- 2020-12-04 EP EP20824979.7A patent/EP4069690B1/en active Active
- 2020-12-04 KR KR1020227012753A patent/KR20220110726A/ko active Pending
- 2020-12-04 WO PCT/GB2020/053107 patent/WO2021111142A1/en not_active Ceased
- 2020-12-04 DK DK20824979.7T patent/DK4069690T3/da active
- 2020-12-04 HU HUE20824979A patent/HUE069799T2/hu unknown
- 2020-12-04 LT LTEPPCT/GB2020/053107T patent/LT4069690T/lt unknown
- 2020-12-04 US US17/782,232 patent/US12491182B2/en active Active
-
2022
- 2022-06-01 CO CONC2022/0007808A patent/CO2022007808A2/es unknown
- 2022-06-02 CL CL2022001464A patent/CL2022001464A1/es unknown
- 2022-06-05 SA SA522432879A patent/SA522432879B1/ar unknown
-
2025
- 2025-10-15 US US19/359,464 patent/US20260060980A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20230028714A1 (en) | 2023-01-26 |
| ES3000984T3 (es) | 2025-03-04 |
| SI4069690T1 (sl) | 2025-03-31 |
| BR112022006259A2 (pt) | 2022-06-21 |
| CO2022007808A2 (es) | 2022-06-30 |
| CN114746415B (zh) | 2025-04-11 |
| CN114746415A (zh) | 2022-07-12 |
| US12491182B2 (en) | 2025-12-09 |
| MX2022006654A (es) | 2022-09-07 |
| SA522432879B1 (ar) | 2025-01-26 |
| DK4069690T3 (da) | 2025-01-20 |
| EP4509179A2 (en) | 2025-02-19 |
| LT4069690T (lt) | 2025-01-10 |
| KR20220110726A (ko) | 2022-08-09 |
| SMT202400514T1 (it) | 2025-01-14 |
| PL4069690T3 (pl) | 2025-03-10 |
| GB201917867D0 (en) | 2020-01-22 |
| EP4509179A3 (en) | 2025-02-26 |
| EP4069690B1 (en) | 2024-11-13 |
| HUE069799T2 (hu) | 2025-04-28 |
| RS66401B1 (sr) | 2025-02-28 |
| US20260060980A1 (en) | 2026-03-05 |
| HRP20250042T1 (hr) | 2025-03-14 |
| EP4069690A1 (en) | 2022-10-12 |
| PT4069690T (pt) | 2024-12-13 |
| WO2021111142A1 (en) | 2021-06-10 |
| JP2023505227A (ja) | 2023-02-08 |
| CL2022001464A1 (es) | 2023-03-24 |
| FI4069690T3 (fi) | 2025-01-21 |
| IL293401A (en) | 2022-07-01 |
| AU2020397613A1 (en) | 2022-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3155829A1 (en) | PC945 TRIAZOLE ANTIFUNGAL COMPOUND POLYMORPHS | |
| IL320185A (en) | Heterocyclic compound | |
| GB202302314D0 (en) | Compound | |
| GB202301239D0 (en) | Compound | |
| GB202216325D0 (en) | Compound | |
| EP4501912A4 (en) | NEW HETEROCYCLIC COMPOUND | |
| ZA202408061B (en) | Benzotriazole compound | |
| CA3271513A1 (en) | Heterocyclic compound | |
| CA3278972A1 (en) | Novel heterocyclic compounds | |
| CA3270589A1 (en) | Novel triheterocyclic compounds | |
| HK40063460A (en) | Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound | |
| HK40098216A (en) | Pyridazinone compound as parp7 inhibitor | |
| TWI922507B (zh) | 新穎化合物 | |
| CA3305044A1 (en) | Novel compounds | |
| CA3300951A1 (en) | Novel compounds | |
| CA3273747A1 (en) | Novel anti-senescence compounds | |
| AU2023902838A0 (en) | Novel Compounds | |
| HK40114176A (en) | Polymorphs as erbb inhibitors | |
| HK40128852A (en) | Novel compounds | |
| GB202304355D0 (en) | Compound | |
| GB202302315D0 (en) | Compound | |
| GB202217826D0 (en) | Compound | |
| GB202217852D0 (en) | Compound | |
| GB202217856D0 (en) | Compound | |
| GB202217854D0 (en) | Compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220803 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20240924 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241122 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241122 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241122 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250123 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250517 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250517 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20250808 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250813 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D149 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S INTERVIEW Effective date: 20250818 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20251103 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20251103 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251119 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251119 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260407 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260407 |